VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

Clinical trial NCT00117351 · TERMINATED

Trial details

NCT number: NCT00117351
Sponsor: Millennium Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Adenocarcinoma, Bronchiolo-Alveolar

Start date: 2005-04-01
Primary completion: 2007-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.